{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T01:23:10Z","timestamp":1769822590490,"version":"3.49.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003484","name":"Heinrich-Heine-Universit\u00e4t D\u00fcsseldorf","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To analyze the impact of the COVID-19 pandemic on medical care and vaccination acceptance of vasculitis patients in Germany.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A web-based national survey was developed by rheumatology centers and vasculitis patient advocacy groups. The survey was distributed nationwide by mail and flyers and could be accessed via a QR-code or weblink from December 2021 to April 2022. Descriptive statistics [mean, median, standard derivation (SD), 25%, 75% quantile] were calculated. 95% confidence intervals were presented for responses that were directly related to the impact of COVID-19 on parameters associated with vasculitis patient care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The online survey was completed by 117 patients with small and large vessel vasculitis [granulomatosis with polyangiitis (<jats:italic>n<\/jats:italic> = 69), eosinophilic granulomatosis with polyangiitis (<jats:italic>n<\/jats:italic> = 16), microscopic polyangiitis (<jats:italic>n<\/jats:italic> = 12), giant cell arteritis (<jats:italic>n<\/jats:italic> = 17) and Takayasu's arteritis (<jats:italic>n<\/jats:italic> = 3)]. Prescheduled rheumatological appointments had been canceled due to the COVID-19 pandemic in 12.6% of the respondents [95% confidence interval (CI), 7.3\u201320.0%); in 9% (95% CI, 4.5\u201315.6%)] appointments had been replaced by digital services. Therapeutic regimens were changed (shifted, reduced, or discontinued) due to the pandemic in 15.5% (95% CI 9.5\u201322.2%). Vaccination coverages were generally high compared to patients with other rheumatic diseases and the general population. Highest vaccination coverage was observed against COVID-19 (98.1% 95% CI 93.9\u201399.6%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Vasculitis patients experienced changes in medical care during COVID-19 pandemic such as cancelation of prescheduled rheumatology appointments and modifications in therapeutic regimens. The overall acceptance rate for vaccination was comparatively high, particularly for vaccination against COVID-19.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.1103694","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T11:31:06Z","timestamp":1673263866000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["COVID-19 pandemic impairs medical care of vasculitis patients in Germany: Results of a national patient survey"],"prefix":"10.3389","volume":"9","author":[{"given":"Anna","family":"Kernder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Filla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Hellmich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Holle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Lamprecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Moosig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolas","family":"Ruffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof","family":"Specker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Vordenb\u00e4umen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamal","family":"Chehab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e001505","DOI":"10.1136\/rmdopen-2020-001505","article-title":"Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry","volume":"7","author":"Glintborg","year":"2021","journal-title":"RMD Open."},{"key":"B3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s43045-022-00184-2","article-title":"Psychosocial and clinical impact of COVID-19 pandemic and its relationship to the quality of life in patients with rheumatoid arthritis: a cross-sectional study, Egypt","volume":"29","author":"Hassan","year":"2022","journal-title":"Middle East Curr Psychiatry."},{"key":"B4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00393-020-00799-y","article-title":"Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2\/Covid-19 pandemic","volume":"79","author":"Schulze-Koops","year":"2020","journal-title":"Z Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/annrheumdis-2020-217628","article-title":"Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2\/COVID-19 pandemic","volume":"79","author":"Schulze-Koops","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1136\/annrheumdis-2020-217987","article-title":"Response to: \u2018Treatment adherence of patients with sytemic rheumatic diseases in COVID-19 pandemic' by Fragoulis et al","volume":"80","author":"Schulze-Koops","year":"2021","journal-title":"Ann Rheum Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1136\/annrheumdis-2020-217877","article-title":"EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2","volume":"79","author":"Landew\u00e9","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00393-021-01055-7","article-title":"Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2\/COVID-19 pandemic, including recommendations for COVID-19 vaccination","volume":"80","author":"Specker","year":"2021","journal-title":"Z Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.25646\/8776","article-title":"Beschluss der STIKO zur 8. Aktualisierung der COVID-19-Impfempfehlung und die dazugeh\u00f6rige wissenschaftliche Begr\u00fcndung","volume":"4","author":"Vygen-Bonnet","year":"2021","journal-title":"Epid Bull"},{"key":"B10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/vaccines10020253","article-title":"COVID-19 vaccination coverage in patients with rheumatic diseases in a german outpatient clinic: an observational study","volume":"10","author":"Krasselt","year":"2022","journal-title":"Vaccines."},{"key":"B11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3899\/jrheum.210534","article-title":"Improving COVID-19 vaccine coverage in patients with autoimmune and inflammatory diseases","volume":"49","author":"Goulenok","year":"2022","journal-title":"J Rheumatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e589","DOI":"10.1002\/iid3.589","article-title":"COVID-19 vaccination in patients with rheumatic diseases: Vaccination rates, patient perspectives, and side effects","volume":"10","author":"Li","year":"2022","journal-title":"Immun Inflamm Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/annrheumdis-2014-206350","article-title":"2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations","volume":"74","author":"Van der Heijde","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.2196\/jmir.6.3.e34","article-title":"Improving the quality of web surveys: the checklist for reporting results of internet e-surveys (CHERRIES)","volume":"6","author":"Eysenbach","year":"2004","journal-title":"J Med Internet Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1214\/ss\/1009213286","article-title":"Interval estimation for a binomial proportion","volume":"16","author":"Brown","year":"2001","journal-title":"Stat Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.25646\/9285.3","article-title":"Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) beim Robert Koch-Institut 2022","volume":"4","author":"St\u00e4ndige","year":"2022","journal-title":"Epid Bull"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.25646\/9436","article-title":"Impfquoten bei Erwachsenen in Deutschland - Aktuelles aus der KV-Impfsurveillance","volume":"50","author":"Rieck","year":"2021","journal-title":"Epid Bull."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e707","DOI":"10.1016\/S2665-9913(21)00175-2","article-title":"Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases","volume":"3","author":"Hausmann","year":"2021","journal-title":"Lancet Rheumatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3899\/jrheum.201623","article-title":"Impact of COVID-19 pandemic on rheumatology practice in latin America","volume":"48","author":"Fern\u00e1ndez-\u00c1vila","year":"2022","journal-title":"J Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1016\/j.ekir.2021.08.009","article-title":"ANCA Vasculitis induction management during the COVID-19 pandemic","volume":"6","author":"Salas","year":"2021","journal-title":"Kidney Int Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s00296-021-04975-4","article-title":"Managing ANCA-associated vasculitis during the COVID-19 pandemic: results from an online survey","volume":"41","author":"Kopp","year":"2021","journal-title":"Rheumatol Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.3906\/sag-2010-267","article-title":"A single center survey study of systemic vasculitis and COVID-19 during the first months of pandemic","volume":"51","author":"Ince","year":"2021","journal-title":"Turk J Med Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1136\/annrheumdis-2020-218697","article-title":"Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries","volume":"80","author":"Dejaco","year":"2021","journal-title":"Ann Rheum Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1136\/annrheumdis-2020-219498","article-title":"Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry","volume":"80","author":"Strangfeld","year":"2021","journal-title":"Ann Rheum Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.1016\/S2665-9913(21)00059-X","article-title":"COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study","volume":"3","author":"Avouac","year":"2021","journal-title":"Lancet Rheumatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","article-title":"Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis","volume":"371","author":"Guillevin","year":"2014","journal-title":"N Engl J Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1136\/annrheumdis-2014-206404","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial","volume":"74","author":"Jones","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"102986","DOI":"10.1016\/j.autrev.2021.102986","article-title":"The COVID-19 pandemic and ANCA-associated vasculitis \u2013 reports from the EUVAS meeting and EUVAS education forum","volume":"28","author":"Kronbichler","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1093\/rheumatology\/kez589","article-title":"All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type","volume":"59","author":"Wallace","year":"2020","journal-title":"Rheumatol Oxf Engl."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e28305","DOI":"10.1097\/MD.0000000000028305","article-title":"Mortality predictors in ANCA-associated vasculitis","volume":"100","author":"Dagostin","year":"2021","journal-title":"Medicine."},{"key":"B32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/imj.15142","article-title":"Immunosuppression as a risk factor for COVID-19: a meta-analysis","volume":"51","author":"Tassone","year":"2021","journal-title":"Intern Med J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1016\/j.vaccine.2018.06.065","article-title":"Predictors for influenza vaccine acceptance among patients with inflammatory rheumatic diseases","volume":"36","author":"Harrison","year":"2018","journal-title":"Vaccine."},{"key":"B34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s15006-020-9517-8","article-title":"Impfquoten bei Erwachsenen: H\u00f6her, aber nicht hoch genug","volume":"163","author":"Starostzik","year":"2021","journal-title":"MMW Fortschr Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.ajkd.2019.04.031","article-title":"ANCA-Associated Vasculitis: Core Curriculum 2020","volume":"75","author":"Geetha","year":"2020","journal-title":"Am J Kidney Dis Off J Natl Kidney Found."},{"key":"B36","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.semarthrit.2021.06.001","article-title":"Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: a population-based study","volume":"51","author":"Muratore","year":"2021","journal-title":"Semin Arthritis Rheum."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1103694\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T11:31:12Z","timestamp":1673263872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1103694\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":36,"alternative-id":["10.3389\/fmed.2022.1103694"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1103694","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"article-number":"1103694"}}